Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism

NCT03757923 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.

NCT NCT03757923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03757923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism
Lead sponsor
Dow University of Health Sciences
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 18, 2018
Completion date
January 31, 2019
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperandrogenism, menstrual irregularities